Technical Analysis for SNGX - Soligenix, Inc.

Grade Last Price % Change Price Change
grade C 0.9571 0.75% 0.01
SNGX closed up 3.26 percent on Tuesday, November 19, 2019, on 79 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical SNGX trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.75%
Earnings Movers Other 0.75%
Fell Below 50 DMA Bearish 4.03%
200 DMA Support Bullish 4.03%
Earnings Movers Other 4.03%
Down 3 Days in a Row Weakness 4.03%
Down 4 Days in a Row Weakness 4.03%
Down 5 Days in a Row Weakness 4.03%
Fell Below 20 DMA Bearish 2.20%
MACD Bearish Signal Line Cross Bearish 2.20%

Older signals for SNGX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable segments: BioTherapeutics and BioDefense. The BioTherapeutics business segment intends to develop orBec ' (oral beclomethasone dipropionate, or oral BDP) and other biotherapeutic products, including LPM TM Leuprolide. The BioDefense business segment intends to convert its ricin toxin vaccine and radiation injury programs from early stage development to advanced development and manufacturing. Soligenix, Inc, formerly known as DOR BioPharma, Inc, is headquartered in Princeton, New Jersey.
Cancer Manufacturing Radiation Proteins Late Stage Biopharmaceutical Biological Warfare Lectins Toxins
Is SNGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.39
52 Week Low 0.65
Average Volume 50,607
200-Day Moving Average 0.9065
50-Day Moving Average 0.9328
20-Day Moving Average 0.9596
10-Day Moving Average 0.9888
Average True Range 0.0572
ADX 13.57
+DI 17.4478
-DI 23.922
Chandelier Exit (Long, 3 ATRs ) 0.9284
Chandelier Exit (Short, 3 ATRs ) 1.0216
Upper Bollinger Band 1.0525
Lower Bollinger Band 0.8667
Percent B (%b) 0.45
BandWidth 19.362234
MACD Line 0.0079
MACD Signal Line 0.0131
MACD Histogram -0.0052
Fundamentals Value
Market Cap 5.44 Million
Num Shares 5.72 Million
EPS -1.35
Price-to-Earnings (P/E) Ratio -0.70
Price-to-Sales 1.70
Price-to-Book 3.25
PEG Ratio -1.40
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.00
Resistance 3 (R3) 0.99 0.97 0.99
Resistance 2 (R2) 0.97 0.96 0.97 0.99
Resistance 1 (R1) 0.96 0.95 0.97 0.97 0.98
Pivot Point 0.94 0.94 0.94 0.94 0.94
Support 1 (S1) 0.93 0.93 0.93 0.93 0.92
Support 2 (S2) 0.91 0.92 0.91 0.91
Support 3 (S3) 0.90 0.91 0.91
Support 4 (S4) 0.90